Sun Pharma Advanced Research Company

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue7.878.451,85563.5853.65
Expenses83.6676.4494.0684.2577.96
EBITDA-65.71-56.641,775-10.34-21.99
EBIT-68.27-71.571,773-12.54-24.19
Profit Before Tax-75.79-80.351,761-20.67-24.31
Net Profit-75.85-80.421,761-20.78-24.39
Financial Ratios
Operating Profit Margin-836.01%-816.57%13,447%-25.90%-73.23%
Net Profit Margin-965.01%-805.56%13,343%-52.05%-81.22%
Earning Per Share (Diluted)-2.34-2.4854.27-0.64-0.75
Dividends Per Share0.000.000.000.000.00